Estonia - RECs and Medical Research
History
The University of Tartu founded a multifunctional ethics commission in 1990 and a similar committee was established in 1993 at the Institute of Experimental & Clinical Medicine in Tallinn. These were renamed in 1999 as Human Research Ethics Committees in Tartu and Medical Research Ethics committee in Tallinn.
In 1998 the Ministry of Social Affairs set up the Estonian Council on Bioethics as a national co-ordinating centre. It acts in an advisory capacity to health authorities and government. This Ministry is also responsible for the requirements for membership, and the remit of, ethics committees.
The State Agency of Medicine, established in 1991, is the body responsible for final authorisation of clinical trials.
There is a separate committee, established in 2001, that deals solely with the Estonian Genome Project
The new Medicinal Products Act entered into force on 1 March 2005. The previous Act from 1996, amended on several times has been repealed together with several lower implementing Acts in full.
The new Act regulates RECs under Chapter 5, Articles 87 to 99. The new Act implements a number of European directives –including Directive 2001/20 and provides comprehensive regulation of the manufacture, handling, distribution, marketing, prescribing, advertising and authorising of medicinal products (both human and veterinary) and provides the rules for supervision and liability.
A decree by the Ministry of Social affairs is expected to fully implement these provisions.
Summary of Estonian RECs
| Type of REC | Human Research Ethics Committee | Medical Research Ethics Committee |
| Where situated? | University of Tartu | National Institute for Health Development, Tallinn |
| Who applies to them? |
Researchers
conducting |
Researchers
conducting· Clinical Trials Doctoral research Master level study projects |
| Formal/Informal | Formal - legal requirement for clinical trials | Formal - legal requirement for clinical trials |
| National/Regional | National | National |
| Laws Involved |
Medicinal
Products Act 2005 |
Medicinal
Products Act 2005 Decree No.77 (2001) of the Ministry of Social Affairs |
| Guidance Involved |
Declaration
of Helsinki |
Declaration
of Helsinki |
| Membership requirements |
At least 7 members
|
At least 7 members
|
| Responsible/accountable to whom? | ||
| Approval or Advisory powers | Approval | Approval |
Not submitting research or failing to follow review
Approval by an ethics committee is mandatory for clinical trials according to the Medicinal Products Act
Which body, if not the REC itself takes this action, and how do they proceed?
The State Agency of Medicines is the extra-judicial body which conducts proceedings in the case of misdemeanours in clinical trials. Relevant laws they may utilise are the Medicinal Products Act and the Code of Misdemeanour Procedure. They can suspend trials and impose fines.
Impact of Directive 2001/20 EC
There will be a time limit of 60 days for an REC to give an opinion.
Legal action that can be taken against RECs
There would appear to be no legal
action that can be taken against RECs.
Links section
- Ministry of Social Affairs (in Estonian, Russian & English)
- Medicinal Products Act (in Estonian & English)
- State Agency of Medicines (in Estonian & English)
- Ethics Committee of the Estonian Genome Project (in Estonian, Russian & English)
- Estonian
Genome Foundation
Articles
- Tikk, Arvo, Parve, Valdar 'Ethics Committees in Estonia' In Ethics Committees in Central and Eastern Europe. J. Glasa. Strasbourg, Council of Europe (2000).
See the REC bibliography section for more links and papers, and the Data Protection Page
